March 2011 Central Nervous System

Controlled substances are often diverted from legitimate patients in the home and health care settings.

Initial research findings sometimes diminish over time. Does this phenomenon apply to drug interactions?

Drug therapy for depression is steeped in controversy. As the debate about antidepressants' effectiveness continues, pharmacists must familiarize themselves with their complexity.

With generic prescriptions on the rise, every pharmacist needs a through understanding of therapeutic equivalence and the generic approval process.

A drug manufacturer is sued over an adverse effect, and pharmacy dispensing records are entered as evidence.

This difficult condition affects both patients and caregivers and the pharmacist can offer needed counseling.

Attention-deficit/hyperactivity disorder is a complex developmental condition that often negatively influences a patient's academic, professional, or social life. Treatment is usually multifaceted and complicated, and requires careful monitoring.

The impact of overactive bladder on quality of life is a major concern and pharmacists can help patients with this common condition.

The FDA approved Kapvay (clonidine hydrochloride extended -release) as a monotherapy and adjunctive therapy for the treatment of attention- deficit/hyperactivity disorder in children and adolescents aged 6 to 17 years.

Although acetaminophen is considered very safe, unintentional overdosing is a serious problem.

There are more OTC analgesics that there are types of headaches, and patients need help making a safe and effective choice.

Back pain is often preventable, but when it strikes, there are many products that promise relief, including pills, patches, belts, compresses, and topical treatments.